Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | TARSTarsus Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $451.36M |
| Revenue, yoy | +146.7% |
| Net income | $66.42M |
| Net income, yoy | +42.5% |
| Net margin | -14.7% |
| Free cash flow | $22.31M |
| FCF margin | -4.9% |
| EPS, diluted | $1.59 |
Add another company.